Skip to content

Responsibility in Drug Advertising Act of 2025

Health

119-hr1117 — Responsibility in Drug Advertising Act of 2025. Sponsored by Rep. DeLauro, Rosa L. [D-CT-3]. Introduced 2025-02-07. House bill. 119th Congress. Latest action: Referred to the House Committee on Energy and Commerce.

119-hr1117 119th Congress House
XML Congress.gov
Sponsor
Rep. DeLauro, Rosa L. [D-CT-3] (D), CT
Introduced
2025-02-07
Committees
Energy and Commerce Committee
Subjects
Broadcasting, cable, digital technologies; Drug safety, medical device, and laboratory regulation; Internet, web applications, social media; Marketing and advertising; Prescription drugs
Latest Action
Referred to the House Committee on Energy and Commerce.

No roll-call vote data available for this bill.

Similar Bills

  • 118-hr9142 — Responsibility in Drug Advertising Act of 2024 89% match 118th Congress
  • 119-s483 — Responsibility in Drug Advertising Act of 2025 77% match
  • 118-s4785 — Responsibility in Drug Advertising Act of 2024 71% match 118th Congress
  • 119-hr4007 — PHARA Act of 2025 53% match
  • 115-hr4385 — Responsibility in Drug Advertising Act of 2017 47% match 115th Congress
Investigate this bill → Beneficiary scoring, topic classification, and fiscal analysis